VYNE Therapeutics
VYNE
#10275
Rank
ยฃ9.54 M
Marketcap
ยฃ0.29
Share price
1.46%
Change (1 day)
-86.71%
Change (1 year)

VYNE Therapeutics (VYNE) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ3.03 Million

According to VYNE Therapeutics's latest financial reports the company's total liabilities are ยฃ3.03 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

VYNE Therapeutics - Total liabilities on balance sheet (from 2016 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ11.8 M68.09%
2023-12-31ยฃ7.02 M-11.06%
2022-12-31ยฃ7.89 M-42.09%
2021-12-31ยฃ13.63 M-66.95%
2020-12-31ยฃ41.26 M407.58%
2019-12-31ยฃ8.13 M8.05%
2018-12-31ยฃ7.52 M-91.79%
2017-12-31ยฃ91.67 M58.22%
2016-12-31ยฃ57.94 M43.49%
2015-12-31ยฃ40.37 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
ยฃ18.2 M 500.22%๐Ÿ‡บ๐Ÿ‡ธ USA